A longhauler trial - which will never happen unless we have approval from CD12- would be a complete waste of time and money. I am quite certain they already know this. Even if it does have some efficacy, which Dr. Patterson doubts, we'll never complete and prove anything in time to make any money off of this indication. It's another red herring tossed out there because we are stalling on the things that we actually have a chance to monetize in the next 12 months. This should be obvious to anyone who has watched this company for a couple of years.